Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma

Research output: Book/ReportPh.D. thesisResearch

Standard

Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma. / Brodin, Nils Patrik.

The Niels Bohr Institute, Faculty of Science, University of Copenhagen, 2013. 45 p.

Research output: Book/ReportPh.D. thesisResearch

Harvard

Brodin, NP 2013, Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma. The Niels Bohr Institute, Faculty of Science, University of Copenhagen. <https://soeg.kb.dk/permalink/45KBDK_KGL/fbp0ps/alma99122551158205763>

APA

Brodin, N. P. (2013). Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma. The Niels Bohr Institute, Faculty of Science, University of Copenhagen. https://soeg.kb.dk/permalink/45KBDK_KGL/fbp0ps/alma99122551158205763

Vancouver

Brodin NP. Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma. The Niels Bohr Institute, Faculty of Science, University of Copenhagen, 2013. 45 p.

Author

Brodin, Nils Patrik. / Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma. The Niels Bohr Institute, Faculty of Science, University of Copenhagen, 2013. 45 p.

Bibtex

@phdthesis{09f72e663cb54cf092bee2ba9205af6b,
title = "Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma",
abstract = "Medulloblastoma (MB) is one of the most common brain tumors in children and most patients will survive their disease if treated with surgery, radio- and chemotherapy. This has resulted in a growing number of MB survivors who are at risk of developing severe late complications related to the aggressive anti-cancer therapy. Some of the most important late complications for these patients include secondary malignancies, cardiac events and neurocognitive decline. Much of the late complication risk can be attributed the craniospinal irradiation which is part of standard management, since this results in irradiating a large volume of healthy tissue in these young patients. The general aim of this thesis is reducing the risk of late treatment toxicity through risk-based advanced radiotherapy optimization. We specifically investigated the use of radiobiological models to estimate late complication risks, developed a mathematical framework for comparing different risks on a common scale and the assessed the potential clinical benefit of sparing critical neurological structures during cranial irradiation. We also developed a mathematical tumor control model for standard-risk MB to assess the effect on treatment efficacy from applying different risk-based treatment strategies.",
author = "Brodin, {Nils Patrik}",
year = "2013",
language = "English",
publisher = "The Niels Bohr Institute, Faculty of Science, University of Copenhagen",

}

RIS

TY - BOOK

T1 - Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma

AU - Brodin, Nils Patrik

PY - 2013

Y1 - 2013

N2 - Medulloblastoma (MB) is one of the most common brain tumors in children and most patients will survive their disease if treated with surgery, radio- and chemotherapy. This has resulted in a growing number of MB survivors who are at risk of developing severe late complications related to the aggressive anti-cancer therapy. Some of the most important late complications for these patients include secondary malignancies, cardiac events and neurocognitive decline. Much of the late complication risk can be attributed the craniospinal irradiation which is part of standard management, since this results in irradiating a large volume of healthy tissue in these young patients. The general aim of this thesis is reducing the risk of late treatment toxicity through risk-based advanced radiotherapy optimization. We specifically investigated the use of radiobiological models to estimate late complication risks, developed a mathematical framework for comparing different risks on a common scale and the assessed the potential clinical benefit of sparing critical neurological structures during cranial irradiation. We also developed a mathematical tumor control model for standard-risk MB to assess the effect on treatment efficacy from applying different risk-based treatment strategies.

AB - Medulloblastoma (MB) is one of the most common brain tumors in children and most patients will survive their disease if treated with surgery, radio- and chemotherapy. This has resulted in a growing number of MB survivors who are at risk of developing severe late complications related to the aggressive anti-cancer therapy. Some of the most important late complications for these patients include secondary malignancies, cardiac events and neurocognitive decline. Much of the late complication risk can be attributed the craniospinal irradiation which is part of standard management, since this results in irradiating a large volume of healthy tissue in these young patients. The general aim of this thesis is reducing the risk of late treatment toxicity through risk-based advanced radiotherapy optimization. We specifically investigated the use of radiobiological models to estimate late complication risks, developed a mathematical framework for comparing different risks on a common scale and the assessed the potential clinical benefit of sparing critical neurological structures during cranial irradiation. We also developed a mathematical tumor control model for standard-risk MB to assess the effect on treatment efficacy from applying different risk-based treatment strategies.

UR - https://soeg.kb.dk/permalink/45KBDK_KGL/fbp0ps/alma99122551158205763

M3 - Ph.D. thesis

BT - Risk-based optimization of photon and proton radiotherapy for pediatric medulloblastoma

PB - The Niels Bohr Institute, Faculty of Science, University of Copenhagen

ER -

ID: 97901500